Merck&#39;s FDA Delay, Pfizer&#39;s Problem
472584
NEW YORK - In a capstone to the withdrawal of Vioxx, the US Food and Drug Administration has decided to delay the approval of successor drug Arcoxia until more safety data are available.
201667
WALL STREET analysts last night said a second experimental pain killer under development by Merck, the American drugs maker, could be delayed until 2007, after regulators asked for more information on the medicineâs safety.
667
The Food and Drug Administration insists that until pharmaceutical giant Merck presented new information this week, there was not enough evidence to pull the arthritis drug Vioxx off the market.
313580
People who take Merck &amp; Co. Inc.&#39;s analgesic Vioxx are nearly three times as likely to have heart attacks as those taking Pfizer Inc.
34442
Pfizer is the latest drug maker to warn that a product already on the market may pose serious health risks. It took outrage from activists in September to get the Food and Drug Administration to require warning
350800
NEW YORK, Nov. 11 -- The 40 percent share price slide in Merck &#38; Co. in the five weeks after it pulled the painkiller Vioxx off the market highlighted larger problems in the pharmaceutical industry that may depress performance for years, according to academics and stock analysts who follow the sector.
29190
NEW YORK - The withdrawal of the arthritis drug Vioxx two weeks ago was a disaster for Merck. But it also put rival Pfizer in a fix.
615822
When Merck&#39;s arthritis drug Vioxx was withdrawn from the market in September, concerns over drug safety were pretty much under the radar for the most part, but not today.
675656
Now that Merck &amp; Co. has removed its arthritis painkiller Vioxx from the market after tests found that it increased the risk of heart attacks and strokes, its rival Pfizer is taking a surprising stance.
140996
A day late and possibly several millions of dollars short. That's the scenario facing one drug manufacturer unless it can get a helping hand from Congress.
631357
Safety problems with Vioxx could have been detected in months rather than years if the Food and Drug Administration had been able to sift through health-care information already compiled privately on one in three Americans.
362559
Drug investors may be wishing they could pop two pills and feel better in the morning. The latest headache hit last week when Pfizer joined the rash of drug companies announcing problems with their products.
524656
The cardiovascular risk boogeyman is everywhere. First it struck Merck&#39;s (NYSE: MRK) Vioxx. Then Pfizer&#39;s (NYSE: PFE) Celebrex.
315772
Merck (MRK:NYSE - news - research) shares fell early Thursday after a study sponsored by the Food and Drug Administration concluded that its Vioxx arthritis drug put users at a greater risk to heart attacks than Pfizer&#39;s (PFE:NYSE - news - research
398323
Still reeling from Merck&#39;s withdrawal of Vioxx from the market and Pfizer&#39;s decision to stop advertising Celebrex, people who suffer from arthritis pain now have one more worry: The US Food and Drug Administration announced Monday that it was halting a
158632
When Raymond Gilmartin became chairman of the drug maker Merck, it was close to introducing several new medicines. Now, the company is in crisis.
218911
While an FDA committee reviewing Procter &amp; Gamble&#39;s testosterone patch for women didn&#39;t say no last week, it clearly said, &quot;Slow.